Article Versions Notes

Salamonowicz-Bodzioch M, Rosa M, Frączkiewicz J, Gorczyńska E, Gul K, Janeczko-Czarnecka M, Jarmoliński T, Kałwak K, Mielcarek-Siedziuk M, Olejnik I, et al. Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia. Journal of Clinical Medicine. 2021; 10(19):4416. https://doi.org/10.3390/jcm10194416

Salamonowicz-Bodzioch, Małgorzata, Monika Rosa, Jowita Frączkiewicz, Ewa Gorczyńska, Katarzyna Gul, Małgorzata Janeczko-Czarnecka, Tomasz Jarmoliński, Krzysztof Kałwak, Monika Mielcarek-Siedziuk, Igor Olejnik, and et al. 2021. "Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia" Journal of Clinical Medicine 10, no. 19: 4416. https://doi.org/10.3390/jcm10194416

Salamonowicz-Bodzioch, M., Rosa, M., Frączkiewicz, J., Gorczyńska, E., Gul, K., Janeczko-Czarnecka, M., Jarmoliński, T., Kałwak, K., Mielcarek-Siedziuk, M., Olejnik, I., Owoc-Lempach, J., Panasiuk, A., Gajek, K., Rybka, B., Ryczan-Krawczyk, R., & Ussowicz, M. (2021). Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia. Journal of Clinical Medicine, 10(19), 4416. https://doi.org/10.3390/jcm10194416